美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

First Trust Health Care AlphaDEX Fund

131.21

+1.551.19%

成交量：4.61萬

成交額：603.70萬

市值：11.41億

市盈率：- -

高：131.23

開：131.16

低：130.55

收：129.66

52周最高：135.82

52周最低：104.53

股本：870.00萬

流通股本：870.00萬

量比：1.28

換手率：0.53%

股息：1.02

股息率：0.78%

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

Organon宣佈美國FDA受理Miudella®無激素宮內節育器補充新藥申請

告別跑腿！虹口優撫對象醫療補助實現「免申即享」

118款生物藥專利懸崖將至，中國藥企業迎戰MNC最大專利懸崖

美國醫療保險和醫療補助服務中心：禁止11家涉嫌欺詐金額超過34億美元的醫療用品公司未來獲得聯邦醫療保險優勢計劃C部分和D

諾和諾德(NVO.US)減肥藥拓展低齡市場：STEP Young試驗顯示司美格魯肽顯著降低兒童肥胖率

諾和諾德(NVO.US)減肥藥拓展低齡市場：STEP Young試驗顯示司美格魯肽顯著降低兒童肥胖率

美國衞生與公眾服務部醫療保險和醫療補助服務中心：特朗普政府宣佈撥款1.2億美元，用於擴大印第安納州母嬰健康服務，提高初級

Thyme Care獲逾20億美元估值融資：摩根健康、西維斯健康創投與哈門那等戰略投資者入局

美國醫療巨頭哈門那（HUM）宣佈派息方案每股派息0.885美元

Hims & Hers在澳大利亞推出GLP-1減肥藥及治療方案

美國醫療保險和醫療補助服務中心：將為阿肯色州農村醫院提供資金，用於升級救護車、拓展遠程醫療服務並安裝應急發電機

不止步於「減肥藥之王」禮來(LLY.US)擬最高28.8億美元收購Merida加碼自身免疫賽道

不止步於「減肥藥之王」禮來(LLY.US)擬最高28.8億美元收購Merida加碼自身免疫賽道

印度糖尿病全球第二多，月費降至14美元，GLP-1減肥藥為何仍賣不動？

华尔街见闻

美國醫療保險和醫療補助服務中心：特朗普政府宣佈撥款9330萬美元，用於在佐治亞州擴展遠程醫療服務、推進手術機器人技術及改

中國減肥藥研發公司德睿智藥稱AI助力研發時間縮短一半

美國醫療保險和醫療補助服務中心：特朗普政府宣佈撥款1.44億美元，用於改善心理健康、藥物濫用、急診及孕產婦護理，並擴大阿

惠譽評級：美國醫療保健網絡風險日益增加。

減肥藥營銷「戰事」升級：從名人「代言」到老闆下場，藥企在焦慮什麼？

法院批准哈門那子公司助理上訴許可

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/hant/stock/FXH/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"FXH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FXH\",,,,,undefined,":{"symbol":"FXH","market":"US","secType":"STK","nameCN":"First Trust Health Care AlphaDEX Fund","latestPrice":131.205,"timestamp":1789403190695,"preClose":129.66,"halted":0,"volume":46092,"delay":0,"changeRate":0.01191577973160586,"floatShares":8700002,"shares":8700002,"eps":0,"marketStatus":"交易中","change":1.545,"latestTime":"09-14 12:26:53 EDT","open":131.16,"high":131.23,"low":130.551,"amount":6036986.35296,"amplitude":0.005237,"askPrice":131.22,"askSize":273,"bidPrice":131.17,"bidSize":273,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1789416000000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":129.66,"sharesOutstanding":7900002,"nav":129.34,"aum":1125258258.68,"dividendRate":0.007807,"bidAskSpread":0.00058,"postHourTrading":{"tag":"盘后","latestPrice":129.66,"preClose":129.66,"latestTime":"19:30 EDT","volume":30,"amount":3886.87,"timestamp":1789169406838,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.27935,"impliedVol":0.1356,"impliedVolPercentile":0.3466},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FXH\",,,,,undefined,":{"symbol":"FXH","floatShares":8700002,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.27935,"shares":8700002,"dividePrice":1.0243,"high":131.23,"amplitude":0.005237,"preClose":129.66,"low":130.551,"week52Low":104.525,"pbRate":"--","week52High":135.8199,"institutionHeld":0,"latestPrice":131.205,"eps":0,"divideRate":0.007807,"volume":46092,"delay":0,"ttmEps":0,"open":131.16,"prevYearClose":113.8213,"prevWeekClose":129.66,"prevMonthClose":132.89,"prevQuarterClose":122.4,"fiveDayClose":133.456,"twentyDayClose":131.22,"sixtyDayClose":115.94},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FXH\",params:#limit:5,,,undefined,":[{"date":"2026-06-25","symbol":"FXH","amount":0.1183,"announcedDate":"2026-06-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-25","defaultRemindTime":1782394200000,"name":"First Trust Health Care AlphaDEX Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-30","payableDate":"2026-06-25","currency":"USD","dateTimestamp":1782360000000,"payDate":"2026-06-30"},{"date":"2026-03-26","symbol":"FXH","amount":0.1858,"announcedDate":"2026-03-25","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-26","defaultRemindTime":1774531800000,"name":"First Trust Health Care AlphaDEX Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-31","payableDate":"2026-03-26","currency":"USD","dateTimestamp":1774497600000,"payDate":"2026-03-31"},{"date":"2025-12-12","symbol":"FXH","amount":0.1399,"announcedDate":"2025-12-11","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-12","defaultRemindTime":1765549800000,"name":"First Trust Health Care AlphaDEX Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-31","payableDate":"2025-12-12","currency":"USD","dateTimestamp":1765515600000,"payDate":"2025-12-31"},{"date":"2025-09-25","symbol":"FXH","amount":0.5821,"announcedDate":"2025-09-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-25","defaultRemindTime":1758807000000,"name":"First Trust Health Care AlphaDEX Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-25","currency":"USD","dateTimestamp":1758772800000,"payDate":"2025-09-30"},{"date":"2025-06-26","symbol":"FXH","amount":0.0616,"announcedDate":"2025-06-25","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-26","defaultRemindTime":1750944600000,"name":"First Trust Health Care AlphaDEX Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-30","payableDate":"2025-06-26","currency":"USD","dateTimestamp":1750910400000,"payDate":"2025-06-30"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FXH\",market:\"US\",,,undefined,":[{"executeDate":"2022-09-23","recordDate":"2022-09-26","paymentDate":"2022-09-30","value":0.1007,"currency":"USD"},{"executeDate":"2022-12-23","recordDate":"2022-12-27","paymentDate":"2022-12-30","value":0.1214,"currency":"USD"},{"executeDate":"2023-03-24","recordDate":"2023-03-27","paymentDate":"2023-03-31","value":0.0438,"currency":"USD"},{"executeDate":"2023-06-27","recordDate":"2023-06-28","paymentDate":"2023-06-30","value":0.0377,"currency":"USD"},{"executeDate":"2023-09-22","recordDate":"2023-09-25","paymentDate":"2023-09-29","value":0.0332,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FXH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"FXH\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1182027615","title":"Organon宣佈美國FDA受理Miudella®無激素宮內節育器補充新藥申請","url":"https://stock-news.laohu8.com/highlight/detail?id=1182027615","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182027615?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 19:31","pubTimestamp":1789385477,"startTime":"0","endTime":"0","summary":"Organon & Co今日宣布，美国食品药品监督管理局已正式受理其针对Miudella——一款无激素宫内节育器——提交的补充新药申请并进入审查流程。Miudella作为一种非激素类的宫内节育系统，旨在为女性提供长效、可逆的避孕选择，同时规避激素相关副作用。Organon公司表示，若获批，Miudella将为那些寻求非激素避孕方案的女性带来新的治疗选项，进一步丰富公司在女性健康领域的产品组合。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4559","LU2065169927.USD","LU2065171311.SGD","BK4007","LU2065171402.SGD","FXH","BK4585","OGN","LU2065170008.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666560676","title":"告別跑腿！虹口優撫對象醫療補助實現「免申即享」","url":"https://stock-news.laohu8.com/highlight/detail?id=2666560676","media":"滚动播报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666560676?lang=zh_tw&edition=fundamental","pubTime":"2026-09-10 19:00","pubTimestamp":1789038000,"startTime":"0","endTime":"0","summary":"街道工作人员向前来咨询的残疾退役军人老王介绍。随后老王在街道工作人员的指导下，完成《告知承诺书》签署。作为全市试点，优抚对象医疗补助在虹口区率先实现“免申即享”。记者了解到，优抚对象就诊后，区退役军人事务部门在扣除各类救助、互助及减负金额后，按规定发放医疗补助。优抚对象还能通过“随申办市民云”APP等渠道查询补助明细与发放进度，实现补助申领“零申请、零材料、零跑动”。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-09-10/doc-inirixkn8584730.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["RSPH","LU0266013472.USD","BK4585","LU0348723411.USD","HUM","BK4588","SG9999014021.USD","LU0238689110.USD","LU0256863811.USD","SG9999014005.SGD","BK4566","BK4154","LU0208291251.USD","LU0320765489.SGD","LU1093756325.SGD","BK4533","IHF","LU0170899867.USD","LU1983260115.SGD","LU1093756168.USD","SG9999014013.SGD","LU0417517546.SGD","LU0070302665.USD","FXH","LU0211331839.USD","LU0390134368.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666563124","title":"118款生物藥專利懸崖將至，中國藥企業迎戰MNC最大專利懸崖","url":"https://stock-news.laohu8.com/highlight/detail?id=2666563124","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666563124?lang=zh_tw&edition=fundamental","pubTime":"2026-09-10 15:26","pubTimestamp":1789025185,"startTime":"0","endTime":"0","summary":"BCG合伙人杜菁博士指出，未来几年全球MNC将迎来史上最大专利悬崖，有118种生物制剂将会失去相应的专利保护，涉及2340亿美元市场。然而，目前这118款即将到期分子中，只有极少数在火热开发，大量缺口有待生物类似药填补。目前来说，创新药出海还没办法完成这个闭环，但生物类似药作为先头部队做出海试验，企业风险和获益会更高。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1789025064363150858","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["RSPH","159839","PJP","BBP","APXH","BME","MEDI","TMED","PBPH","GSKH","IHE","BBH","IYH","PPH","TRUH","FXH","JDOC","FHLC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666743903","title":"美國醫療保險和醫療補助服務中心：禁止11家涉嫌欺詐金額超過34億美元的醫療用品公司未來獲得聯邦醫療保險優勢計劃C部分和D","url":"https://stock-news.laohu8.com/highlight/detail?id=2666743903","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666743903?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 01:20","pubTimestamp":1788888000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["UN","UNHW","IEHS","LU1093756168.USD","LU0320765489.SGD","UNHG","BK4566","LU0070302665.USD","BK4585","LU0390134368.USD","LU0238689110.USD","LU0266013472.USD","BK4154","RSPH","HUM","LU1093756325.SGD","SG9999014005.SGD","SG9999014021.USD","FXH","BK4588","LU0208291251.USD","LU0348723411.USD","LU0211331839.USD","LU0256863811.USD","LU1983260115.SGD","LU0417517546.SGD","BK4533","UNHU","SG9999014013.SGD","LU0170899867.USD","IHF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665311633","title":"諾和諾德(NVO.US)減肥藥拓展低齡市場：STEP Young試驗顯示司美格魯肽顯著降低兒童肥胖率","url":"https://stock-news.laohu8.com/highlight/detail?id=2665311633","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665311633?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 20:15","pubTimestamp":1788783311,"startTime":"0","endTime":"0","summary":"诺和诺德在声明中指出，这项名为STEP Young的试验所纳入的全部受试者，在整个研究期间均接受了生活方式干预，包括限制热量摄入和增加体育锻炼。诺和诺德首席科学官马丁·霍尔斯特·兰格表示：“STEP Young试验的积极结果令人振奋，我们看好司美格鲁肽在帮助罹患肥胖的儿童方面的潜力——这些儿童除生活方式调整外，尚需药物治疗以更有效地管理其肥胖状况。”","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1493013.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["NBDS","FXH","NVOC","MEDI","THNR","NVOH","TRUH","CURE","NVOX","PJP","FHLC","PINK","RSPH","IYH","BGIA","XLVI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665311616","title":"諾和諾德(NVO.US)減肥藥拓展低齡市場：STEP Young試驗顯示司美格魯肽顯著降低兒童肥胖率","url":"https://stock-news.laohu8.com/highlight/detail?id=2665311616","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665311616?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 20:15","pubTimestamp":1788783311,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["PJP","IYH","RSPH","THNR","PINK","CURE","NBDS","NVOH","XLVI","BGIA","NVOX","NVOC","TRUH","MEDI","FHLC","FXH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664877326","title":"美國衞生與公眾服務部醫療保險和醫療補助服務中心：特朗普政府宣佈撥款1.2億美元，用於擴大印第安納州母嬰健康服務，提高初級","url":"https://stock-news.laohu8.com/highlight/detail?id=2664877326","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664877326?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 21:22","pubTimestamp":1788441723,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0390134368.USD","LU0211331839.USD","RSPH","SG9999014013.SGD","LU0348723411.USD","LU0208291251.USD","LU0320765489.SGD","XBI","LU1983260115.SGD","BK4533","LU0256863811.USD","LU0070302665.USD","LU0417517546.SGD","SG9999014005.SGD","LU0170899867.USD","BK4588","LU1093756325.SGD","LU1093756168.USD","FXH","SG9999014021.USD","LU0238689110.USD","IHF","HUM","LU0266013472.USD","BK4566","BK4585","BK4581","BK4154","LABU","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162980197","title":"Thyme Care獲逾20億美元估值融資：摩根健康、西維斯健康創投與哈門那等戰略投資者入局","url":"https://stock-news.laohu8.com/highlight/detail?id=1162980197","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162980197?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 23:06","pubTimestamp":1788361574,"startTime":"0","endTime":"0","summary":"Thyme Care近日宣布完成新一轮融资，公司估值已突破20亿美元大关。此轮投资方阵容颇为亮眼——摩根健康、西维斯健康创投及哈门那纷纷入局，此外还有多家战略支付方与医疗服务提供者共同参与了本次投资。这轮融资不仅为Thyme Care注入了强劲的资本动力，更标志着其商业模式获得了来自医疗健康产业链核心环节的广泛认可。截至目前，Thyme Care尚未披露具体融资金额。此番资本的聚合，究竟将为Thyme Care开辟何种发展路径，市场正拭目以待。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0238689110.USD","BK4533","LU1059921491.USD","LU2357627491.SGD","IHF","IE00BZ1G4Q59.USD","LU2125909247.SGD","LU0006061336.USD","LU0072461881.USD","LU1983299246.USD","BK4581","BK4588","LU0061475181.USD","LU0432979614.USD","SG9999014013.SGD","LU0390134368.USD","BK4585","LU1093756168.USD","IE00B19Z3581.USD","BK4550","LU0162691827.USD","LU0170899867.USD","LU0211331839.USD","HUM","LU0417517546.SGD","LU1699723380.USD","LU2125909593.SGD","SG9999014005.SGD","IE00B7SZLL34.SGD","BK4504","LU1571399168.USD","LU0348723411.USD","IE0002270589.USD","FXH","LU1236620750.USD","CVS","LU0208291251.USD","BK4154","LU0070302665.USD","LU0266013472.USD","LU1923622614.USD","LU2433249047.HKD","IE00B19Z3B42.SGD","IE00BKVL7J92.USD","LU1093756325.SGD","SG9999014021.USD","LU1983260115.SGD","IE00BSNM7G36.USD","LU0256863811.USD","BK4196","LU0320765489.SGD","RTH","LU1236620834.HKD","LU0859254822.USD","BK4566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664816858","title":"美國醫療巨頭哈門那（HUM）宣佈派息方案 每股派息0.885美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2664816858","media":"金吾财讯","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664816858?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 19:12","pubTimestamp":1788347570,"startTime":"0","endTime":"0","summary":"金吾财讯 | 哈门那（HUM）公告，公司董事会批准现金分红，每股派息0.885美元。股权登记日为2026年10月30日收盘，股息将于2026年11月27日完成兑付。哈门那是美国大型医疗健康企业，业务涵盖保险与医疗服务，主要服务联邦医保、医疗补助参保者以及军人群体。","market":"sh","thumbnail":"https://static.szfiu.com/news/20210625/ZGFjNmMxNjJiOWZlZTExMTI2OTIxOTcyMDA=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210625/ZGFjNmMxNjJiOWZlZTExMTI2OTIxOTcyMDA=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"305626","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0208291251.USD","SG9999014013.SGD","LU0266013472.USD","LU0256863811.USD","LU0170899867.USD","LU0417517546.SGD","LU0211331839.USD","LU0390134368.USD","UDN","SG9999014005.SGD","BK4585","LU0070302665.USD","SG9999014021.USD","LU0348723411.USD","LU1093756325.SGD","BK4154","HUM","UUP","159891","BK4588","IHF","LU0238689110.USD","LU0320765489.SGD","VIG","FXH","LU1093756168.USD","BK4566","LU1983260115.SGD","BK4533"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664882140","title":"Hims & Hers在澳大利亞推出GLP-1減肥藥及治療方案","url":"https://stock-news.laohu8.com/highlight/detail?id=2664882140","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664882140?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 10:10","pubTimestamp":1788228656,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["JDOC","THNR","LLYX","FHLC","OZEM","ELIL","CURE","PJP","NBDS","NVOC","MEDI","NVOX","PINK","ELIS","RSPH","LLII","XLVI","FXH","NVOH","TRUH","IYH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664008470","title":"美國醫療保險和醫療補助服務中心：將為阿肯色州農村醫院提供資金，用於升級救護車、拓展遠程醫療服務並安裝應急發電機","url":"https://stock-news.laohu8.com/highlight/detail?id=2664008470","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664008470?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 02:18","pubTimestamp":1788200331,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0070302665.USD","LU0348723411.USD","IEIH","UN","UNHG","EKG","HUM","IEHS","LU0208291251.USD","FDHT","SG9999014005.SGD","HEAL","LU0211331839.USD","LGHT","LU0170899867.USD","SG9999014021.USD","FXH","UNHU","LU0390134368.USD","IHF","BK4154","BK4585","BK4566","UNHW","LU1093756325.SGD","LU0320765489.SGD","LU0417517546.SGD","LU0266013472.USD","BK4533","BMED","SG9999014013.SGD","BK4588","LU1093756168.USD","LU1983260115.SGD","RSPH","LU0256863811.USD","GDOC","HTEC","LU0238689110.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663006809","title":"不止步於「減肥藥之王」 禮來(LLY.US)擬最高28.8億美元收購Merida加碼自身免疫賽道","url":"https://stock-news.laohu8.com/highlight/detail?id=2663006809","media":"智通财经","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663006809?lang=zh_tw&edition=fundamental","pubTime":"2026-08-31 21:12","pubTimestamp":1788181963,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，礼来计划以高达28.8亿美元的现金收购Merida Biosciences Inc.，加码自身免疫与过敏疾病领域，以摆脱对减重和糖尿病两大支柱业务的过度依赖——正是这两大市场助其登顶全球药企市值之巅。今年以来，礼来掀起并购狂潮，迄今已宣布的交易总额超过200亿美元。5月，礼来还达成协议，以最高38亿美元收购三家疫苗研发企业。截至发稿，礼来盘前跌0.2%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1489847.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["NVOC","NVOH","IYH","TRUH","XLVI","PJP","FXH","RSPH","THNR","PINK","NBDS","MEDI","FHLC","NVOX","CURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663006800","title":"不止步於「減肥藥之王」 禮來(LLY.US)擬最高28.8億美元收購Merida加碼自身免疫賽道","url":"https://stock-news.laohu8.com/highlight/detail?id=2663006800","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663006800?lang=zh_tw&edition=fundamental","pubTime":"2026-08-31 21:12","pubTimestamp":1788181963,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["NVOX","TRUH","NVOH","CURE","RSPH","IYH","FHLC","PJP","NVOC","THNR","MEDI","NBDS","PINK","XLVI","FXH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663168590","title":"印度糖尿病全球第二多，月費降至14美元，GLP-1減肥藥為何仍賣不動？","url":"https://stock-news.laohu8.com/highlight/detail?id=2663168590","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663168590?lang=zh_tw&edition=fundamental","pubTime":"2026-08-29 05:55","pubTimestamp":1787954138,"startTime":"0","endTime":"0","summary":"印度减肥药市场正在给全球制药行业上一堂关于市场预期的警示课。尽管GLP-1类药物在印度已实现大规模仿制、价格降至每月14美元，销售表现却远逊于预期，揭示出价格之外更深层的文化、社会与监管障碍。截至今年7月，约三十余种仿制GLP-1药物已在印度药房上市。市场冷淡直接冲击了制药行业对印度的增长押注。印度市场本被视为GLP-1药物向美欧以外拓展的重要试验场。","market":"sh","thumbnail":"https://static.tigerbbs.com/62df7fa563e423b513600a842a6669e3","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/62df7fa563e423b513600a842a6669e3"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3780608","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELIS","NVOC","FXH","PJP","RSPH","JDOC","XLVI","ELIL","LLYX","TRUH","PINK","UDN","MNDmain","CURE","NBDS","IYH","OZEM","THNR","MEDI","FHLC","LLII","NVOX","UUP","NVOH"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2662702216","title":"美國醫療保險和醫療補助服務中心：特朗普政府宣佈撥款9330萬美元，用於在佐治亞州擴展遠程醫療服務、推進手術機器人技術及改","url":"https://stock-news.laohu8.com/highlight/detail?id=2662702216","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662702216?lang=zh_tw&edition=fundamental","pubTime":"2026-08-27 20:14","pubTimestamp":1787832855,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["UNHG","BK4585","SG9999014013.SGD","BMED","LU1093756325.SGD","IHF","RSPH","LU0390134368.USD","FDHT","LU0348723411.USD","UNHU","LU0170899867.USD","LU0208291251.USD","LU0211331839.USD","UN","LU0417517546.SGD","HTEC","LGHT","UNHW","BK4588","IEHS","HEAL","LU0256863811.USD","BK4154","LU0320765489.SGD","HUM","EKG","SG9999014021.USD","SG9999014005.SGD","MDEV","IEIH","LU1093756168.USD","GDOC","LU0266013472.USD","LU1983260115.SGD","LU0070302665.USD","BK4533","LU0238689110.USD","BK4566","FXH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662376416","title":"中國減肥藥研發公司德睿智藥稱AI助力研發時間縮短一半","url":"https://stock-news.laohu8.com/highlight/detail?id=2662376416","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662376416?lang=zh_tw&edition=fundamental","pubTime":"2026-08-26 12:03","pubTimestamp":1787717002,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["ARTY","PJP","AGIX","CHAT","IYH","NVOC","MEDI","TRUH","FXH","AIPO","PINK","QTOC","NBDS","THNR","NVOH","CURE","RSPH","NVOX","XLVI","FHLC","VTHR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662420944","title":"美國醫療保險和醫療補助服務中心：特朗普政府宣佈撥款1.44億美元，用於改善心理健康、藥物濫用、急診及孕產婦護理，並擴大阿","url":"https://stock-news.laohu8.com/highlight/detail?id=2662420944","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662420944?lang=zh_tw&edition=fundamental","pubTime":"2026-08-25 05:51","pubTimestamp":1787608316,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["RSPH","UNHU","LU0417517546.SGD","LU1983260115.SGD","LU0208291251.USD","SG9999014021.USD","LU1093756325.SGD","UN","LU0320765489.SGD","IEHS","BK4533","SG9999014013.SGD","FXH","LU0348723411.USD","BK4154","UNHG","UNHW","LU0211331839.USD","BK4588","BK4585","LU0390134368.USD","LU0238689110.USD","SG9999014005.SGD","BK4566","IHF","LU0256863811.USD","LU0266013472.USD","HUM","LU0170899867.USD","LU0070302665.USD","LU1093756168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660649212","title":"惠譽評級：美國醫療保健網絡風險日益增加。","url":"https://stock-news.laohu8.com/highlight/detail?id=2660649212","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660649212?lang=zh_tw&edition=fundamental","pubTime":"2026-08-19 04:43","pubTimestamp":1787085794,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["PTH","IYH","MOAT","PINK","XLVI","HYLG","FXH","BK4588","BK4585","JHMH","RSPH","CURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660490484","title":"減肥藥營銷「戰事」升級：從名人「代言」到老闆下場，藥企在焦慮什麼？","url":"https://stock-news.laohu8.com/highlight/detail?id=2660490484","media":"澎湃新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660490484?lang=zh_tw&edition=fundamental","pubTime":"2026-08-17 18:59","pubTimestamp":1786964340,"startTime":"0","endTime":"0","summary":"2026年以来，国内减肥药赛道的宣发动作愈发密集且新颖。8月16日，一场银屑病慢病管理公益计划在上海启动，活动聚焦于银屑病与肥胖的关系。背后的支持方是信达生物（1801.HK），该公司拥有已经获批的银屑病创新药匹康奇拜单抗，也手握国内明星GLP-1药物玛仕度肽。将其他疾病与肥胖话题关联起来，此次活动侧面打开了减肥药宣传的新思路。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608173843343562.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608173843343562.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["RSPH","TRUH","FXH","IYH","CURE","PJP","THNR","PINK","NBDS","FHLC","XLVI","MEDI","NVOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108678606","title":"法院批准哈門那子公司助理上訴許可","url":"https://stock-news.laohu8.com/highlight/detail?id=1108678606","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108678606?lang=zh_tw&edition=fundamental","pubTime":"2026-08-14 21:20","pubTimestamp":1786713624,"startTime":"0","endTime":"0","summary":"8月14日（路透社）——哈门那公司（Humana AB）宣布，上诉法院已正式批准其子公司哈门那助理公司（Humana Assistans AB）的上诉请求。该上诉涉及地方法院此前驳回其针对国家损害赔偿诉讼的裁决。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1983260115.SGD","LU0320765489.SGD","LU0170899867.USD","LU0070302665.USD","IHF","BK4566","FXH","BK4154","HUM","LU0238689110.USD","SG9999014005.SGD","LU0211331839.USD","SG9999014021.USD","LU0266013472.USD","LU0208291251.USD","LU0348723411.USD","BK4585","LU1093756168.USD","LU0256863811.USD","LU1093756325.SGD","LU0390134368.USD","SG9999014013.SGD","LU0417517546.SGD","BK4588","BK4533"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":69,"code":"91000000","status":"200"}]}}